Early study supports freezing for prostate cancer
This article was originally published in Clinica
Executive Summary
Cryoablation is an effective treatment for prostate cancer, reduces complications and costs less than either radiotherapy or surgery. Preliminary data from 310 patients show only 10% recurrence, although follow-up ranges from only three months to two years, Dr Duke Bahn of the Crittenton Hospital, Rochester, Minnesota, told the American Roentgen Ray Society's annual meeting in Washington last month. Dr Bahn says complications are infrequent and incontinence is only 1% compared with about 30% in surgery patients.